The products excluded from DSCSA

Back in September, the Office of Inspector General (OIG) published a report on Distributor Readiness for DSCSA.  We discussed the findings in a blog post on our site a couple of weeks ago.  At this time, we wanted to take a deeper dive into another interesting area...

FDA meeting

The FDA hosted representatives of the healthcare industry for the Summer DSCSA meeting on August 23rd. 2017.  This article is RXTransparent’s summary of the meeting and represents  our opinion and our opinion only.  As with previous RXTransparent publications,...

Proud to be a Member of PACT

RXTransparent is proud to announce our new membership in the Philadelphia Alliance for Capital & Technologies (PACT). The strategic partners and relationships we have developed through PACT have proven to be invaluable in the growth trajectory of RXTransparent....